231 related articles for article (PubMed ID: 18056867)
1. The butyrylcholinesterase knockout mouse as a model for human butyrylcholinesterase deficiency.
Li B; Duysen EG; Carlson M; Lockridge O
J Pharmacol Exp Ther; 2008 Mar; 324(3):1146-54. PubMed ID: 18056867
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
3. Prolonged toxic effects after cocaine challenge in butyrylcholinesterase/plasma carboxylesterase double knockout mice: a model for butyrylcholinesterase-deficient humans.
Duysen EG; Lockridge O
Drug Metab Dispos; 2011 Aug; 39(8):1321-3. PubMed ID: 21540357
[TBL] [Abstract][Full Text] [Related]
4. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
[TBL] [Abstract][Full Text] [Related]
5. The butyrylcholinesterase knockout mouse a research tool in the study of drug sensitivity, bio-distribution, obesity and Alzheimer's disease.
Duysen EG; Li B; Lockridge O
Expert Opin Drug Metab Toxicol; 2009 May; 5(5):523-8. PubMed ID: 19416087
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-transduced human butyrylcholinesterase in mouse blood functions as a bioscavenger of chemical warfare nerve agents.
Chilukuri N; Duysen EG; Parikh K; diTargiani R; Doctor BP; Lockridge O; Saxena A
Mol Pharmacol; 2009 Sep; 76(3):612-7. PubMed ID: 19542320
[TBL] [Abstract][Full Text] [Related]
7. Whole body and tissue imaging of the butyrylcholinesterase knockout mouse injected with near infrared dye labeled butyrylcholinesterase.
Duysen EG; Lockridge O
Chem Biol Interact; 2008 Sep; 175(1-3):119-24. PubMed ID: 18486120
[TBL] [Abstract][Full Text] [Related]
8. Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase.
Boudinot E; Taysse L; Daulon S; Chatonnet A; Champagnat J; Foutz AS
Pharmacol Biochem Behav; 2005 Jan; 80(1):53-61. PubMed ID: 15652380
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated gene transfer of human butyrylcholinesterase results in persistent high-level transgene expression in vivo.
Chilukuri N; Duysen EG; Parikh K; Sun W; Doctor BP; Lockridge O; Saxena A
Chem Biol Interact; 2008 Sep; 175(1-3):327-31. PubMed ID: 18499092
[TBL] [Abstract][Full Text] [Related]
10. Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase.
Wang Y; Boeck AT; Duysen EG; Van Keuren M; Saunders TL; Lockridge O
Toxicol Appl Pharmacol; 2004 May; 196(3):356-66. PubMed ID: 15094306
[TBL] [Abstract][Full Text] [Related]
11. A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India.
Manoharan I; Boopathy R; Darvesh S; Lockridge O
Clin Chim Acta; 2007 Mar; 378(1-2):128-35. PubMed ID: 17182021
[TBL] [Abstract][Full Text] [Related]
12. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.
Gätke MR; Bundgaard JR; Viby-Mogensen J
Pharmacogenet Genomics; 2007 Nov; 17(11):995-9. PubMed ID: 18075469
[TBL] [Abstract][Full Text] [Related]
13. Gene-delivered butyrylcholinesterase is prophylactic against the toxicity of chemical warfare nerve agents and organophosphorus compounds.
Parikh K; Duysen EG; Snow B; Jensen NS; Manne V; Lockridge O; Chilukuri N
J Pharmacol Exp Ther; 2011 Apr; 337(1):92-101. PubMed ID: 21205915
[TBL] [Abstract][Full Text] [Related]
14. Naturally occurring mutation Leu307Pro of human butyrylcholinesterase in the Vysya community of India.
Manoharan I; Wieseler S; Layer PG; Lockridge O; Boopathy R
Pharmacogenet Genomics; 2006 Jul; 16(7):461-8. PubMed ID: 16788378
[TBL] [Abstract][Full Text] [Related]
15. The butyrylcholinesterase knockout mouse is obese on a high-fat diet.
Li B; Duysen EG; Lockridge O
Chem Biol Interact; 2008 Sep; 175(1-3):88-91. PubMed ID: 18452903
[TBL] [Abstract][Full Text] [Related]
16. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
[TBL] [Abstract][Full Text] [Related]
17. Novel mutations in the BCHE gene in patients with no butyrylcholinesterase activity.
On-Kei Chan A; Lam CW; Tong SF; Man Tung C; Yung K; Chan YW; Au KM; Yuen YP; Hung CT; Ng KP; Shek CC
Clin Chim Acta; 2005 Jan; 351(1-2):155-9. PubMed ID: 15563885
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to mouse butyrylcholinesterase.
Mrvova K; Obzerova L; Girard E; Krejci E; Hrabovska A
Chem Biol Interact; 2013 Mar; 203(1):348-53. PubMed ID: 23099085
[TBL] [Abstract][Full Text] [Related]
19. Production of the butyrylcholinesterase knockout mouse.
Li B; Duysen EG; Saunders TL; Lockridge O
J Mol Neurosci; 2006; 30(1-2):193-5. PubMed ID: 17192674
[TBL] [Abstract][Full Text] [Related]
20. Determination of butyrylcholinesterase (BChE) phenotypes to predict the risk of prolonged apnea in persons receiving succinylcholine in the healthy population of western Iran.
Vaisi-Raygani A; Rahimi Z; Kharazi H; Tavilani H; Aminiani M; Kiani A; Vaisi-Raygani A; Pourmotabbed T
Clin Biochem; 2007 Jun; 40(9-10):629-33. PubMed ID: 17350607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
